| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |